MIA in the spotlight at ASCO virtual conference

MIA in the spotlight at ASCO virtual conference

30 May 2020

This year’s American Society of Clinical Oncology (ASCO) Annual Meeting has gone virtual, with researchers from MIA once again in the spotlight. Usually attended by over 40,000 professionals, ASCO’s Annual Meeting showcased global advances in research and treatment, all of which impact patient outcomes.

Headlining MIA’s contribution at ASCO 20 Virtual was Dr Ines Silva, a clinical fellow and post-doctoral researcher at MIA, who was awarded the prestigious Bradley Stuart Beller Endowed award for best abstract.

Dr Silva’s abstract related to an oral presentation delivered virtually at ASCO, assessing the impact of Ipilimumab-based immunotherapy in patients with metastatic melanoma whose disease had already proven resistant to anti-PD1 monotherapy.

The multicentre retrospective study involved 355 patients with Stage III or Stage IV melanoma whose cancer had progressed or recurred despite having anti-PD1 monotherapy. 46% of these patients were then treated with ipilimumab alone, with 54% receiving combination ipilimumab and anti-PD1 therapy.

In patients who received the follow up combination therapy, there was a higher response rate (32%) as well as longer progression free survival (25% at 12 months) and overall survival (58% at 12 months) compared to IPI alone. Importantly, IPI+anti-PD1 was not associated with more severe side effects than IPI monotherapy.

Dr Silva and the MIA team created clinical predictive models to help identify the patients who will benefit from these treatments.

‘It was an honour to deliver the oral presentation virtually at ASCO 20 Virtual,’ said Dr Silva. ‘Although we weren’t together physically, still being able to share insights and learnings globally was vitally important in ensuring we continue on our path to saving more lives from melanoma.’

Also awarded at ASCO 20 Virtual were Dr Adriana Hepner and Dr Lauren Brown who received merit awards for abstracts submitted. Overall, MIA researchers and clinicians contributed to 21 abstracts featured at ASCO.

‘We are extremely proud of our ongoing contribution to the global effort to save lives from melanoma, with Dr Silva’s prestigious award proof that we continue to lead the way in changing the treatment landscape for melanoma patients,’ MIA Co-Medical Director Professor Georgina Long said.

‘Our mission is zero deaths from melanoma, and by collaborating with our colleagues on the world stage we are confident we are on track to reach that goal within our lifetime,’ added MIA Co-Medical Director Professor Richard Scolyer.

Register to view Dr Silva's video and slides here: Dr Silva presentation 

See the ASCO 20 Virtual Program here: ASCO 20 Virtual 

The people behind the Professors
29 Mar 2017

The people behind the Professors

Professor’s Long and Scolyer are well known in the academic community and beloved by their patients. But we wanted to get to know our new Conjoint Medical Directors a little more and hear their plans on making an impact on melanoma.

Wyong Rugby Leagues kicks goal to help end melanoma
28 Mar 2017

Wyong Rugby Leagues kicks goal to help end melanoma

Wyong Rugby League Club Group has joined forces with Melanoma Institute Australia to help end melanoma for future generations.

Melanoma research reaches a milestone
21 Mar 2017

Melanoma research reaches a milestone

Melanoma research has reached a milestone with the 10,000th patient giving their permission for their blood and tissue samples to be used in the world’s largest melanoma biospecimen bank. 

Contributing to the promise of Surgical Oncology
17 Mar 2017

Contributing to the promise of Surgical Oncology

MIA's researchers and clinicians are in Seattle, USA, today sharing their research findings at the prestigious Society of Surgical Oncology’s Annual Cancer Symposium.

Introducing Melanoma Institute Australia's Conjoint Medical Directors
14 Mar 2017

Introducing Melanoma Institute Australia's Conjoint Medical Directors

Two of the world’s best minds in melanoma have taken over the academic and clinical leadership of Melanoma Institute Australia (MIA). Professor Georgina Long and Professor Richard Scolyer are the new Conjoint Medical Directors of MIA, and are shaping the future direction of melanoma research, treatment and education.

A day in the life of... Georgia Cairns CNC
10 Mar 2017

A day in the life of... Georgia Cairns CNC

Meet Georgia, our Clinica Nurse Consultant who provides vital care and education for patients throughout their treatment.

The real tragedy on Married At First Sight that Australia should be talking about....
08 Mar 2017

The real tragedy on Married At First Sight that Australia should be talking about....

Australia, we need to talk. This week’s dramatic episodes of Married At First Sight have highlighted a tragedy which is ripping Australian families apart. Yet no one is talking about it.

Melanoma Institute Australia celebrates International Women's Day
08 Mar 2017

Melanoma Institute Australia celebrates International Women's Day

To celebrate International Women's Day 2017, MIA shares how some of the women who inspire the way we work every day, are showing their commitment to accelerate gender parity.

New Chairman of the Board for Melanoma Institute Australia
01 Mar 2017

New Chairman of the Board for Melanoma Institute Australia

We welcome Mr Grant King to the position of Chairman of the Board of Melanoma Institute Australia, following the retirement of Mr Reg Richardson AM who led the organisation for 10 years.

MIA student honoured with NSW National Council of Women Australia Day Award
10 Feb 2017

MIA student honoured with NSW National Council of Women Australia Day Award

Congratulations to PhD Student, Tuba Nur Gide who was awarded a NSW National Council of Women Australia Day Award for her PhD research work. 

Melanoma Institute Australia joins forces with Wollongong Wolves in the fight against melanoma
06 Feb 2017

Melanoma Institute Australia joins forces with Wollongong Wolves in the fight against melanoma

Melanoma Institute Australia, is joining forces with the Wollongong Wolves Football Club in the battle to reduce Australia’s melanoma rates.

 

Follow-up scans after surgery for melanoma
25 Jan 2017

Follow-up scans after surgery for melanoma

A new research project will evaluate the benefits and economic implications of CT and PET/CT imaging in patients with asymptomatic Stage III melanoma.

Sunscreen tips for a skin smart summer!
25 Jan 2017

Sunscreen tips for a skin smart summer!

Sunscreen tips for a skin smart summer with the help of Professor Pascale Guitera, Dermatologist Associate for Melanoma Institute Australia.

Improving survival in uveal melanoma
11 Jan 2017

Improving survival in uveal melanoma

Although survival rates for people with skin melanoma are increasing, these promises of hope are not being seen in uveal melanoma. Researchers are desperately trying to uncover new ways to treat this disease.

Melanoma patient, Lucinda Ryan taking on melanoma one step at a time
21 Dec 2016

Melanoma prevention and awareness on 720 ABC Perth

Lucinda Ryan and Carole Renouf talking about melanoma preventation and awareness on 720 ABC Perth.

Melanoma research gets a funding boost from NHMRC
09 Dec 2016

Melanoma research gets a funding boost from NHMRC

Research projects led by MIA have been awarded almost $6 million in the latest NHMRC funding round which will enable vital progression of research into melanoma prevention and treatment.

Challenges in melanoma clinical research: A snapshot from the Australasian Melanoma Conference 2016
05 Dec 2016

Challenges in melanoma clinical research

The last decade has seen a surge in therapeutic options for advanced melanoma patients, thanks to research. However, not every patient responds to treatment and researchers are taking on the challenge to find out why.

Global Melanoma Research Report
01 Dec 2016

Global Melanoma Research Report

Our first Global Melanoma Research Report shares selected research from around the world and here at MIA that is making a difference to the lives of melanoma patients now and in the future.

Announcement from Melanoma Institute Australia
24 Nov 2016

Announcement from Melanoma Institute Australia

After 18 years as Director of the Sydney Melanoma Unit and then Executive Director of Melanoma Institute Australia, Professor John Thompson AO will step down from the position at the end of 2016.

Nine practice points from the new melanoma guidelines
17 Nov 2016

Nine practice points from the new melanoma guidelines

Australian melanoma clinical practice guidelines have been published on a wiki platform for the first time as researchers try to keep up to date with emerging evidence.